Both MCP-1 and IL-8 have been implicated in tumor progression by suppressing the tumor-infiltration and anti-tumor activity of monocytes [102] and stimulating angiogenesis and PLC-β and PI3K signaling in endothelial cells [61], respectively. The gene discussed is CCL2; the disease is neoplasm.